Package 0615-8328-39

Brand: divalproex sodium

Generic: divalproex sodium
NDC Package

Package Facts

Identity

Package NDC 0615-8328-39
Digits Only 0615832839
Product NDC 0615-8328
Description

30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8328-39)

Marketing

Marketing Status
Discontinued 2026-05-31
Brand divalproex sodium
Generic divalproex sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5b31a69e-8500-4895-9429-4a3f600bbc72", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099625", "1099678", "1099870"], "spl_set_id": ["0f86c2ad-a13c-457d-8fed-6c3f470a470d"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8328-39)", "package_ndc": "0615-8328-39", "marketing_end_date": "20260531", "marketing_start_date": "20191205"}], "brand_name": "Divalproex Sodium", "product_id": "0615-8328_5b31a69e-8500-4895-9429-4a3f600bbc72", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0615-8328", "generic_name": "Divalproex Sodium", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "500 mg/1"}], "application_number": "ANDA078182", "marketing_category": "ANDA", "marketing_end_date": "20260531", "marketing_start_date": "20140321"}